{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Lead compounds", "Molecular docking", "Molecular dynamics simulation", "Phytochemical inhibitors", "SARS-CoV-2 helicase Nsp13"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34117992", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1007/s11030-021-10251-1"], "Journal": {"ISSN": "1573-501X", "JournalIssue": {"Volume": "26", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Molecular diversity", "ISOAbbreviation": "Mol Divers"}, "ArticleTitle": "Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.", "Pagination": {"StartPage": "429", "EndPage": "442", "MedlinePgn": "429-442"}, "Abstract": {"AbstractText": ["The SARS-CoV-2 helicase Nsp13 is a promising target for developing anti-COVID drugs. In the present study, we have identified potential natural product inhibitors of SARS-CoV-2 Nsp13 targeting the ATP-binding site using molecular docking and molecular dynamics (MD) simulations. MD simulation of the prepared crystal structure of SARS-CoV-2 Nsp13 was performed to generate an ensemble of structures of helicase Nsp13 capturing the conformational diversity of the ATP-binding site. A natural product library of more than 14,000 phytochemicals from Indian medicinal plants was used to perform virtual screening against the ensemble of Nsp13 structures. Subsequently, a two-stage filter, first based on protein-ligand docking binding energy value and second based on protein residues in the ligand-binding site and non-covalent interactions between the protein residues and the ligand in the best-docked pose, was used to identify 368 phytochemicals as potential inhibitors of SARS-CoV-2 helicase Nsp13. MD simulations of the top inhibitors complexed with protein were performed to confirm stable binding, and to compute MM-PBSA based binding energy. From among the 368 potential phytochemical inhibitors, the top identified potential inhibitors of SARS-CoV-2 helicase Nsp13 namely, Picrasidine M, (+)-Epiexcelsin, Isorhoeadine, Euphorbetin and Picrasidine N, can be taken up initially for experimental studies."], "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Institute of Mathematical Sciences (IMSc), Chennai, 600113, India."}, {"Identifier": [], "Affiliation": "Homi Bhabha National Institute (HBNI), Mumbai, 400094, India."}], "LastName": "Vivek-Ananth", "ForeName": "R P", "Initials": "RP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Institute of Mathematical Sciences (IMSc), Chennai, 600113, India. mkukrishna@imsc.res.in."}], "LastName": "Krishnaswamy", "ForeName": "Sankaran", "Initials": "S"}, {"Identifier": ["0000-0002-6796-9604"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Institute of Mathematical Sciences (IMSc), Chennai, 600113, India. asamal@imsc.res.in."}, {"Identifier": [], "Affiliation": "Homi Bhabha National Institute (HBNI), Mumbai, 400094, India. asamal@imsc.res.in."}], "LastName": "Samal", "ForeName": "Areejit", "Initials": "A"}], "GrantList": [{"GrantID": "Ramanujan fellowship (SB/S2/RJN-006/2014)", "Agency": "Science and Engineering Research Board", "Country": ""}, {"GrantID": "Max Planck Partner Group", "Agency": "Max-Planck-Gesellschaft", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Divers", "NlmUniqueID": "9516534", "ISSNLinking": "1381-1991"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet Lond Engl. 2020;395:514\u2013523. doi: 10.1016/S0140-6736(20)30154-9.", "ArticleIdList": ["10.1016/S0140-6736(20)30154-9", "PMC7159286", "31986261"]}, {"Citation": "Kuzikov M, Costanzi E, Reinshagen J, et al. Identification of inhibitors of SARS-CoV-2 3CL-pro enzymatic activity using a small molecule in vitro repurposing screen. ACS Pharmacol Transl Sci. 2021 doi: 10.1021/acsptsci.0c00216.", "ArticleIdList": ["10.1021/acsptsci.0c00216", "PMC7986981", "35287429"]}, {"Citation": "Braga L, Ali H, Secco I, et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature. 2021 doi: 10.1038/s41586-021-03491-6.", "ArticleIdList": ["10.1038/s41586-021-03491-6", "PMC7611055", "33827113"]}, {"Citation": "US Food and Drug Administration (2020) FDA Issues emergency use authorization for potential COVID-19 treatment. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment"}, {"Citation": "Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325\u2013328. doi: 10.1016/j.chom.2020.02.001.", "ArticleIdList": ["10.1016/j.chom.2020.02.001", "PMC7154514", "32035028"]}, {"Citation": "V\u2019kovski P, Kratzel A, Steiner S, et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155\u2013170. doi: 10.1038/s41579-020-00468-6.", "ArticleIdList": ["10.1038/s41579-020-00468-6", "PMC7592455", "33116300"]}, {"Citation": "Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat Rev Drug Discov. 2020;19:149\u2013150. doi: 10.1038/d41573-020-00016-0.", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Shu T, Huang M, Wu D, et al. SARS-coronavirus-2 Nsp13 possesses NTPase and RNA helicase activities that can be inhibited by bismuth salts. Virol Sin. 2020;35:321\u2013329. doi: 10.1007/s12250-020-00242-1.", "ArticleIdList": ["10.1007/s12250-020-00242-1", "PMC7271831", "32500504"]}, {"Citation": "Jia Z, Yan L, Ren Z, et al. Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic Acids Res. 2019;47:6538\u20136550. doi: 10.1093/nar/gkz409.", "ArticleIdList": ["10.1093/nar/gkz409", "PMC6614802", "31131400"]}, {"Citation": "Habtemariam S, Nabavi SF, Banach M, et al. Should we try SARS-CoV-2 helicase inhibitors for COVID-19 therapy? Arch Med Res. 2020;51:733\u2013735. doi: 10.1016/j.arcmed.2020.05.024.", "ArticleIdList": ["10.1016/j.arcmed.2020.05.024", "PMC7261434", "32536457"]}, {"Citation": "White MA, Lin W, Cheng X. Discovery of COVID-19 inhibitors targeting the SARS-CoV-2 Nsp13 helicase. J Phys Chem Lett. 2020;11:9144\u20139151. doi: 10.1021/acs.jpclett.0c02421.", "ArticleIdList": ["10.1021/acs.jpclett.0c02421", "PMC7571306", "33052685"]}, {"Citation": "Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review. Bioorganic Chem. 2021;106:104490. doi: 10.1016/j.bioorg.2020.104490.", "ArticleIdList": ["10.1016/j.bioorg.2020.104490", "PMC7676368", "33261845"]}, {"Citation": "Sumon TA, Hussain MdA, Hasan MdT, et al. A revisit to the research updates of drugs, vaccines, and bioinformatics approaches in combating COVID-19 pandemic. Front Mol Biosci. 2021;7:585899. doi: 10.3389/fmolb.2020.585899.", "ArticleIdList": ["10.3389/fmolb.2020.585899", "PMC7868442", "33569389"]}, {"Citation": "Bhowmick S, Saha A, Osman SM, et al. Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach. Mol Divers. 2021 doi: 10.1007/s11030-021-10214-6.", "ArticleIdList": ["10.1007/s11030-021-10214-6", "PMC8039805", "33844135"]}, {"Citation": "Mirza MU, Froeyen M. Structural elucidation of SARS-CoV-2 vital proteins: computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase. J Pharm Anal. 2020;10:320\u2013328. doi: 10.1016/j.jpha.2020.04.008.", "ArticleIdList": ["10.1016/j.jpha.2020.04.008", "PMC7187848", "32346490"]}, {"Citation": "Ahmad S, Waheed Y, Ismail S, et al. Structure-based virtual screening identifies multiple stable binding sites at the RecA domains of SARS-CoV-2 helicase enzyme. Molecules. 2021;26:1446. doi: 10.3390/molecules26051446.", "ArticleIdList": ["10.3390/molecules26051446", "PMC7962107", "33800013"]}, {"Citation": "Thurakkal L, Singh S, Roy R, et al. An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets. Chem Phys Lett. 2021;763:138193. doi: 10.1016/j.cplett.2020.138193.", "ArticleIdList": ["10.1016/j.cplett.2020.138193", "PMC7666712", "33223560"]}, {"Citation": "Zia M, Muhammad S, Shafiq-urRehman, et al. Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies. Bioorg Med Chem Lett. 2021;43:128079. doi: 10.1016/j.bmcl.2021.128079.", "ArticleIdList": ["10.1016/j.bmcl.2021.128079", "PMC8087859", "33940136"]}, {"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Ren J, Zhang A-H, Wang X-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. 2020;155:104743. doi: 10.1016/j.phrs.2020.104743.", "ArticleIdList": ["10.1016/j.phrs.2020.104743", "PMC7128263", "32145402"]}, {"Citation": "Rastogi S, Pandey DN, Singh RH. COVID-19 pandemic: a pragmatic plan for ayurveda intervention. J Ayurveda Integr Med. 2020 doi: 10.1016/j.jaim.2020.04.002.", "ArticleIdList": ["10.1016/j.jaim.2020.04.002", "PMC7177084", "32382220"]}, {"Citation": "Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, et al. IMPPAT: a curated database of Indian medicinal plants. Phytochem Ther Sci Rep. 2018;8:4329. doi: 10.1038/s41598-018-22631-z.", "ArticleIdList": ["10.1038/s41598-018-22631-z", "PMC5847565", "29531263"]}, {"Citation": "Vivek-Ananth RP, Rana A, Rajan N, et al. In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection. Molecules. 2020;25:3822. doi: 10.3390/molecules25173822.", "ArticleIdList": ["10.3390/molecules25173822", "PMC7504347", "32842606"]}, {"Citation": "The Wealth of India (2000) The wealth of India: a dictionary of Indian raw materials & industrial products. First supplement series (Raw materials) Vol 1. National Institute of Science Communication, Council of Scientific & Industrial Research, New Delhi"}, {"Citation": "The Wealth of India (2000) The wealth of India: a dictionary of Indian raw materials & industrial products. First supplement series (Raw materials) Vol 2. National Institute of Science Communication, Council of Scientific & Industrial Research, New Delhi"}, {"Citation": "The Wealth of India (2000) The wealth of India: a dictionary of Indian raw materials & industrial products. First supplement series (Raw materials) Vol 3. National Institute of Science Communication, Council of Scientific & Industrial Research, New Delhi"}, {"Citation": "The Wealth of India (2000) The wealth of India: a dictionary of Indian raw materials & industrial products. First supplement series (Raw materials) Vol 4. National Institute of Science Communication, Council of Scientific & Industrial Research, New Delhi"}, {"Citation": "The Wealth of India (2000) The wealth of India: a dictionary of Indian raw materials & industrial products. First supplement series (Raw materials) Vol 5. National Institute of Science Communication, Council of Scientific & Industrial Research, New Delhi"}, {"Citation": "Rastogi RP (1990) Compendium of Indian medicinal plants. Vol 1: 1960\u20131969. Central Drug Research Institute, Lucknow"}, {"Citation": "Rastogi RP (1991) Compendium of Indian medicinal plants. Vol 2: 1970\u20131979. Central Drug Research Institute, Lucknow"}, {"Citation": "Rastogi RP (1993) Compendium of Indian medicinal plants. Vol 3: 1980\u20131984. Central Drug Research Institute, Lucknow"}, {"Citation": "Rastogi RP (1995) Compendium of Indian medicinal plants. Vol 4: 1985\u20131989. Central Drug Research Institute, Lucknow"}, {"Citation": "Rastogi RP (1998) Compendium of Indian medicinal plants. Vol 5: 1990\u20131994. Central Drug Research Institute, Lucknow"}, {"Citation": "Chatterjee A, Pakrashi SC (1991) The treatise on Indian medicinal plants. Vol 1. Publications & Information Directorate, Council of Scientific & Industrial Research (India), New Delhi"}, {"Citation": "Chatterjee A, Pakrashi SC (1992) The treatise on Indian medicinal plants. Vol 2. Publications & Information Directorate, Council of Scientific & Industrial Research (India), New Delhi"}, {"Citation": "Chatterjee A, Prakashi SC (1994) The treatise on Indian medicinal plants. Vol 3. Publications & Information Directorate, Council of Scientific & Industrial Research (India), New Delhi"}, {"Citation": "Chatterjee A, Prakashi SC (1995) The treatise on Indian medicinal plants. Vol 4. Publications & Information Directorate, Council of Scientific & Industrial Research (India), New Delhi"}, {"Citation": "Chatterjee A, Prakashi SC (1997) The treatise on Indian medicinal plants. Vol 5. Publications & Information Directorate, Council of Scientific & Industrial Research (India), New Delhi"}, {"Citation": "Chatterjee A, Prakashi SC (2003) The treatise on Indian medicinal plants. Vol 6. Publications & Information Directorate, Council of Scientific & Industrial Research (India), New Delhi"}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3\u201326. doi: 10.1016/s0169-409x(00)00129-0.", "ArticleIdList": ["10.1016/s0169-409x(00)00129-0", "11259830"]}, {"Citation": "Kim S, Chen J, Cheng T, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47:D1102\u2013D1109. doi: 10.1093/nar/gky1033.", "ArticleIdList": ["10.1093/nar/gky1033", "PMC6324075", "30371825"]}, {"Citation": "O\u2019Boyle NM, Banck M, James CA, et al. Open Babel: an open chemical toolbox. J Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "Wlodawer A, Dauter Z, Shabalin IG, et al. Ligand-centered assessment of SARS-CoV-2 drug target models in the protein data bank. FEBS J. 2020;287:3703\u20133718. doi: 10.1111/febs.15366.", "ArticleIdList": ["10.1111/febs.15366", "PMC7276724", "32418327"]}, {"Citation": "Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}, {"Citation": "Abraham MJ, Murtola T, Schulz R, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Schmid N, Eichenberger AP, Choutko A, et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur Biophys J. 2011;40:843. doi: 10.1007/s00249-011-0700-9.", "ArticleIdList": ["10.1007/s00249-011-0700-9", "21533652"]}, {"Citation": "Stroet M, Caron B, Visscher KM, et al. Automated topology builder version 3.0: prediction of solvation free enthalpies in water and hexane. J Chem Theory Comput. 2018;14:5834\u20135845. doi: 10.1021/acs.jctc.8b00768.", "ArticleIdList": ["10.1021/acs.jctc.8b00768", "30289710"]}, {"Citation": "Berendsen HJC, Postma JPM, van Gunsteren WF, et al. Molecular dynamics with coupling to an external bath. J Chem Phys. 1984;81:3684\u20133690. doi: 10.1063/1.448118.", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52:7182\u20137190. doi: 10.1063/1.328693.", "ArticleIdList": ["10.1063/1.328693"]}, {"Citation": "Daura X, Gademann K, Jaun B, et al. Peptide folding: when simulation meets experiment. Angew Chem Int Ed. 1999;38:236\u2013240. doi: 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M.", "ArticleIdList": ["10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.0.CO;2-M"]}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Rodrigues JPGLM, Teixeira JMC, Trellet M, Bonvin AMJJ. pdb-tools: a swiss army knife for molecular structures. F1000Research. 2018;7:1961. doi: 10.12688/f1000research.17456.1.", "ArticleIdList": ["10.12688/f1000research.17456.1", "PMC6343223", "30705752"]}, {"Citation": "Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Schyman P, Liu R, Desai V, Wallqvist A. vNN web server for ADMET predictions. Front Pharmacol. 2017;8:889. doi: 10.3389/fphar.2017.00889.", "ArticleIdList": ["10.3389/fphar.2017.00889", "PMC5722789", "29255418"]}, {"Citation": "Baker NA, Sept D, Joseph S, et al. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci. 2001;98:10037\u201310041. doi: 10.1073/pnas.181342398.", "ArticleIdList": ["10.1073/pnas.181342398", "PMC56910", "11517324"]}, {"Citation": "Kumari R, Kumar R, Open Source Drug Discovery Consortium, Lynn A (2014) g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54:1951\u20131962. 10.1021/ci500020m", "ArticleIdList": ["24850022"]}, {"Citation": "Khare CP. Indian medicinal plants: an illustrated dictionary. New York: Springer; 2007."}, {"Citation": "Mohd Jamil MDH, Taher M, Susanti D, et al. Phytochemistry, traditional use and pharmacological activity of Picrasma quassioides: a critical reviews. Nutrients. 2020;12:2584. doi: 10.3390/nu12092584.", "ArticleIdList": ["10.3390/nu12092584", "PMC7551903", "32858812"]}, {"Citation": "Chen J, Yan X-H, Dong J-H, et al. Tobacco mosaic virus (TMV) inhibitors from Picrasma quassioides Benn. J Agric Food Chem. 2009;57:6590\u20136595. doi: 10.1021/jf901632j.", "ArticleIdList": ["10.1021/jf901632j", "19586051"]}, {"Citation": "Hoang VD, Tan GT, Zhang H-J, et al. Natural anti-HIV agents\u2014part I: (+)-demethoxyepiexcelsin and verticillatol from Litsea verticillata. Phytochemistry. 2002;59:325\u2013329. doi: 10.1016/S0031-9422(01)00454-X.", "ArticleIdList": ["10.1016/S0031-9422(01)00454-X", "11830141"]}, {"Citation": "Guan Y, Wang D, Tan GT, et al. Litsea species as potential antiviral plant sources. Am J Chin Med. 2016;44:275\u2013290. doi: 10.1142/S0192415X16500166.", "ArticleIdList": ["10.1142/S0192415X16500166", "27080941"]}, {"Citation": "Dutta PK, Banerjee D, Dutta NL. Euphorbetin: a new bicoumarin from Euphorbia lathyris L. Tetrahedron Lett. 1972;13:601\u2013604. doi: 10.1016/S0040-4039(01)84388-4.", "ArticleIdList": ["10.1016/S0040-4039(01)84388-4"]}, {"Citation": "Vivek-Ananth RP, Sahoo AK, Kumaravel K, et al. MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi. RSC Adv. 2021;11:2596\u20132607. doi: 10.1039/D0RA10322E.", "ArticleIdList": ["10.1039/D0RA10322E", "PMC8693784", "35424258"]}, {"Citation": "Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10:449\u2013461. doi: 10.1517/17460441.2015.1032936.", "ArticleIdList": ["10.1517/17460441.2015.1032936", "PMC4487606", "25835573"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "26"}, {"Year": "2021", "Month": "6", "Day": "8"}, {"Year": "2021", "Month": "6", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "12", "Hour": "12", "Minute": "11"}, {"Year": "2021", "Month": "6", "Day": "12"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34117992", "PMC8196922", "10.1007/s11030-021-10251-1", "10.1007/s11030-021-10251-1"]}}], "PubmedBookArticle": []}